Frequency of dengue virus infection in blood donors in Sistan and Baluchestan province in Iran

Transfusion and Apheresis Science

Volumn 50, Issue 1, 2014, Pages 59-62

  Aghaie, Afsaneh ^a   Aaskov, John ^b   Chinikar, Sadegh ^c   Niedrig, Matthias ^d   Banazadeh, Soudabeh ^e   Mohammadpour, Hashem Khorsand ^e  

^a HIGH INSTITUTE FOR RESEARCH AND EDUCATION IN TRANSFUSION MEDICINE   (Iran)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^c PASTEUR INSTITUTE OF IRAN   (Iran)

^d ROBERT KOCH INSTITUTE   (Germany)

^e Iranian Blood Research and Fractionation Company   (Iran)

Author keywords

Blood donor; Dengue virus; Iran

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; DENGUE; DENGUE VIRUS; DONOR SELECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE; IRAN; MALE; MIDDLE AGED; NORMAL HUMAN; QUESTIONNAIRE; SCREENING TEST; YOUNG ADULT; BLOOD; FLUORESCENT ANTIBODY TECHNIQUE; GEOGRAPHY; VIROLOGY;

BLOOD DONORS; DENGUE; DENGUE VIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GEOGRAPHY; HEALTHY VOLUNTEERS; HUMANS; IMMUNOGLOBULIN G; IRAN; MALE;

EID: 84897020931     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2013.07.034     Document Type: Article

References (12)

1. Myat Thu H., Lowry K., Jiang L., Hlaing T., Holmes E.C., Aaskov J. Lineage extinction and replacement in dengue type 1 virus populations are due to stochastic events rather than to natural selection. Virology 2005, 336:163-172.
2. Chinikar S., Ghiasi S.M., Moradi M., Madihi S.R. Laboratory detection facility of dengue fever (DF) in Iran. The first imported case. Int J Infect Dis 2010, 8(1). 10.5580/a83.
3. Wiwanitkit V. Non vector-borne transmission modes of dengue. J Infect Dev Ctries 2010, 4:51-54.
4. Pasca A., Mustafa A.S., Chaturvedi U.C. Study of dengue virus infection in Kuwait. Dengue Bulletin 2002, 26:113-116.
5. Lee ching ng Dengue: lessons, challenges and new approaches, challenges in dengue surveillance and control. WPSAR 2011, 2(2):1-3. 10.5365/wpsar.2011.2.2.001.
6. A-Nuegoonpipat A., Berlioz-Arthaud A., Chow V., Endy T., Lowry K., Mai L.Q., et al. Sustained transmission of dengue virus type 1 in the Pacific due to repeated introductions of different Asian strains. Virology 2004, 329:505-512.
7. Ng L.C., Lam S., Teo D. Epidemiology of dengue and chikungunya viruses and their potential impact on the blood supply. ISBT Sci Ser 2009, 4:357-367.
8. Wilder-Smith A., Chen L.H., Massad E., Wilson M.E. Threat of dengue to blood safety in dengue-endemic countries. Emer Infect Dis 2009, 15:8-11.
9. Guzman M.G., Halstead S.B., Artsob H., Buchy P., Farrar J., Gubler D.J., et al. Dengue: a continuing global threat. Nat Rev Microbiol 2010, 8:S7-S16.
10. Chiueh T.S. Transfusion transmission risk of dengue viruses in an endemic area. ISBT Sci Ser 2011, 6:313-315.
11. Tambyah P.A., Koay E.S., Poon M.L., Lin R.V., Ong B.K. Dengue hemorrhagic fever transmitted by blood transfusion. N Engl J Med 2008, 359:1526-1527.
12. Trent D., Shin J., Hombach J., Knezevic I., Minor P. World Health Organization working group on technical specifications for manufacture and evaluation of dengue vaccines. Vaccine Geneva Switzerland 2009, 28:8246-8255.